Saratov Region Secures 145,650 Insulin Aspart Doses for 2026 Beneficiaries

Saratov Region Secures 145,650 Insulin Aspart Doses for 2026 Beneficiaries

Saratov Health Ministry to Purchase Insulin for Beneficiaries Worth 17.4 Million Rubles

Saratov Region Secures 145,650 Insulin Aspart Doses for 2026 Beneficiaries

The Saratov Regional Health Ministry has announced a new procurement of insulin aspart for beneficiaries. The medication will be purchased using funds from the regional budget allocated for healthcare development in 2026. A total of 145,650 doses of insulin aspart will be procured at a unit price of 119.68 rubles. The overall cost of the purchase amounts to 17.43 million rubles. The insulin is scheduled for delivery to the Saratov Pharmaceutical Warehouse by 25 August 2026.

The funds for this procurement come from the 2026 regional state programme 'Healthcare Development'. The ministry aims to ensure beneficiaries receive the necessary medication on time. The procurement will provide essential insulin supplies to those in need across the Saratov region. The delivery deadline and budget allocation have been clearly defined to support the initiative.

Neueste Nachrichten